We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$3.46B
Cap. Flow %
-1.41%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.64%
2 Healthcare 14.1%
3 Financials 12.4%
4 Consumer Discretionary 12.19%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASPU
2876
DELISTED
ASPEN GROUP, INC.
ASPU
$527K ﹤0.01%
+58,203
New +$479K
KVHI icon
2877
KVH Industries
KVHI
$157M
$526K ﹤0.01%
58,942
-3,807
-6% -$33.5K
SHBI icon
2878
Shore Bancshares
SHBI
$796M
$525K ﹤0.01%
47,271
-2,363
-5% -$23.1K
GHM icon
2879
Graham Corp
GHM
$1.31B
$524K ﹤0.01%
41,154
+3,205
+8% +$39.2K
PTVCB
2880
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$524K ﹤0.01%
34,797
-1,998
-5% -$27.9K
USX
2881
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$518K ﹤0.01%
86,400
AQST icon
2882
Aquestive Therapeutics
AQST
$494M
$516K ﹤0.01%
+106,355
New +$490K
ESCA icon
2883
Escalade
ESCA
$311M
$516K ﹤0.01%
36,917
+5,516
+18% +$51.1K
STR
2884
DELISTED
Sitio Royalties
STR
$516K ﹤0.01%
40,296
-59,458
-60% -$624K
CASA
2885
DELISTED
Casa Systems, Inc. Common Stock
CASA
$516K ﹤0.01%
123,995
-99,600
-45% -$421K
PKBK icon
2886
Parke Bancorp
PKBK
$405M
$511K ﹤0.01%
37,710
+2,060
+6% +$26.5K
HBT icon
2887
HBT Financial
HBT
$1.32B
$510K ﹤0.01%
38,264
-4,127
-10% -$49.5K
PVLA
2888
Palvella Therapeutics
PVLA
$2.27B
$508K ﹤0.01%
2,047
-114
-5% -$26.7K
FNHC
2889
DELISTED
FedNat Holding Company Common Stock
FNHC
$508K ﹤0.01%
45,835
-56,382
-55% -$657K
VFL
2890
DELISTED
abrdn National Municipal Income Fund
VFL
$507K ﹤0.01%
41,405
CABA icon
2891
Cabaletta Bio
CABA
$455M
$506K ﹤0.01%
45,420
+28,869
+174% +$221K
NODK icon
2892
NI Holdings
NODK
$320M
$506K ﹤0.01%
34,223
WEYS icon
2893
Weyco Group
WEYS
$440M
$506K ﹤0.01%
23,446
-1,219
-5% -$23.7K
TREC
2894
DELISTED
Trecora Resources
TREC
$504K ﹤0.01%
80,287
-11,673
-13% -$65.3K
BYSI icon
2895
BeyondSpring
BYSI
$35.8M
$503K ﹤0.01%
+33,363
New +$509K
IMXI icon
2896
International Money Express
IMXI
$367M
$501K ﹤0.01%
40,223
-6,548
-14% -$66.6K
MPX
2897
DELISTED
Marine Products Corp
MPX
$501K ﹤0.01%
36,174
-2,252
-6% -$23.6K
NBN icon
2898
Northeast Bank
NBN
$1.14B
$500K ﹤0.01%
28,475
-43
-0.2% -$653
VRA icon
2899
Vera Bradley
VRA
$98.7M
$497K ﹤0.01%
111,992
SPFI icon
2900
South Plains Financial
SPFI
$841M
$496K ﹤0.01%
34,815
-3,082
-8% -$40.2K

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.